An isothermal shift assay for proteome scale drug-target identification
Abstract
Most small molecule drugs act on living systems by physically interacting with specific proteins and modulating target function. Identification of drug binding targets, within the complex milieu of the human proteome, remains a challenging task of paramount importance in drug discovery. Existing approaches for target identification employ complex workflows with limited throughput. Here, we present the isothermal shift assay (iTSA), a mass spectrometry method for proteome-wide identification of drug targets within lysates or living cells. Compared with prevailing methods, iTSA uses a simplified experimental design with increased statistical power to detect thermal stability shifts that are induced by small molecule binding. Using a pan-kinase inhibitor, staurosporine, we demonstrate improved performance over commonly used thermal proteome profiling methods, identifying known targets in cell lysates and living cells. We also demonstrate the identification of both known targets and additional candidate targets for the kinase inhibitor harmine in cell and tissue lysates.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 14, 2020
- Source ID
- 10.1038/s42003-020-0795-6
Entities
People
- Jeremy Jacobsen
- Kerri A. Ball
- Kevin R. Jones
- Kira A. Cozzolino
- Kristofor J. Webb
- Michael Stowell
- Stephen J Coleman
- William M. Old
Organizations
- United States Department of Defense